| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/11/2007 | US7306800 Monoclonal antibody that recognizes a human 8F4 polypeptide, wherein 8F4 polypeptide: is an inducible T cell costimulatory molecule; occurs on two-signal-activated CD4+ T lymphocytes from human peripheral blood; dimer of two peptide chains |
| 12/11/2007 | US7306797 Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
| 12/11/2007 | US7306794 Methods and compositions for the treatment of defects in lipoprotein metabolism |
| 12/11/2007 | US7306793 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 12/11/2007 | US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 12/11/2007 | CA2188463C Pharmaceutical compositions containing activated protein c-resistant factor v for the treatment of bleeding disorders |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/06/2007 | WO2007140410A2 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 12/06/2007 | WO2007140000A2 Administration of the reg1 anticoagulation system |
| 12/06/2007 | WO2007139970A2 Men1 gene for diagnosis and treatment of diabetes |
| 12/06/2007 | WO2007139178A1 Therapeutic agent for alzheimer's disease |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007139120A1 AMYLOID-β CLEARANCE ENHANCER |
| 12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 12/06/2007 | WO2007138253A1 Screening method |
| 12/06/2007 | WO2007138193A1 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 12/06/2007 | WO2007138104A1 Expression vectors comprising the hs1 promoter of the vav1 oncogene and use thereof for the preparation of pharmaceutical compositions intended for somatic gene therapy |
| 12/06/2007 | WO2007137414A1 Overexpression of integrin linked kinase (ilk) to improve post-infarct remodeling |
| 12/06/2007 | WO2007120170A9 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
| 12/06/2007 | WO2007055704A3 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 12/06/2007 | WO2007014077A3 Rnai modulation of the rho-a gene and uses thereof |
| 12/06/2007 | WO2005089231A3 Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide |
| 12/06/2007 | WO2005033277A3 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070281901 Rnai-mediated inhibition of tumor necrosis factor alpha-related conditions |
| 12/06/2007 | US20070281900 COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY |
| 12/06/2007 | US20070281899 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE |
| 12/06/2007 | US20070281896 Novel compositions and methods in cancer |
| 12/06/2007 | US20070281890 Fibroblast Growth Factor-13 |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070281306 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 12/06/2007 | US20070280963 Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors |
| 12/06/2007 | US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses |
| 12/06/2007 | US20070280948 low density lipoprotein receptor-related protein 5 (LRP5) is a cell surface marker for somatic mammary stem cells and mammary tumor stem cells; enriching somatic mammary stem cells by contacting with anti(LRP5) antibody; selecting cells that bind to the antibody |
| 12/06/2007 | US20070280947 Tie Receptor and Tie Ligand Materials and Methods for Modulating Female Fertility |
| 12/06/2007 | US20070280925 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| 12/06/2007 | US20070280908 Treatment of diabetes with synthetic beta cells |
| 12/06/2007 | US20070280907 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells |
| 12/06/2007 | US20070280906 Method to generate mirrored adenoassociated viral vectors |
| 12/06/2007 | US20070280905 Prognosis and Systemic Therapy for Treating Malignancy |
| 12/06/2007 | US20070280903 T1 Receptor-Like Ligand II and Uses Thereof |
| 12/06/2007 | US20070280902 Method for treating eye disease or conditions affecting the posterior segment of the eye |
| 12/06/2007 | US20070280880 Method for cell-specific targeting |
| 12/06/2007 | CA2654033A1 Therapeutic agent for alzheimer's disease |
| 12/06/2007 | CA2653910A1 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 12/05/2007 | EP1862546A1 Enhanced virus-mediated dna transfer |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862470A1 Element retained in blood showing degradability selectively in tumor tissue |
| 12/05/2007 | EP1861491A1 Flavivirus replicon constructs for tumour therapy |
| 12/05/2007 | EP1861118A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 12/05/2007 | EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 12/05/2007 | EP1381393B1 Microparticle protection of therapeutic agents |
| 12/05/2007 | EP1339440B1 An implantable or insertable therapeutic agent delivery device |
| 12/05/2007 | EP0941252B1 Anti-p53 single-chain antibody fragments and their uses |
| 12/05/2007 | EP0932418B1 Method for recombinant adeno-associated virus-directed gene therapy |
| 12/05/2007 | EP0931149B1 A novel haemopoietin receptor and genetic sequences encoding same |
| 12/05/2007 | EP0760675B2 Compositions comprising dna damaging agents and p53 |
| 12/05/2007 | CN101084237A Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 12/05/2007 | CN101084232A Antiviral oligonucleotides |
| 12/05/2007 | CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus |
| 12/05/2007 | CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease |
| 12/05/2007 | CN100352930C Vaccines immunotherapeutics and method for using the same |
| 12/05/2007 | CN100352929C Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element |
| 12/05/2007 | CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352922C SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352828C SMAD4 gene expression-inhibiting SiRNA, its encoding sequence and application |
| 12/05/2007 | CN100352513C Novel mucous membrane vaccine for newcastle disease and its construction method |
| 12/05/2007 | CN100352512C Recombinant human co-stimulatory molecule bacilli-calmette-guerin strain and process for making same |
| 12/05/2007 | CN100352511C Vaccination by topical application of genetic vectors |
| 12/05/2007 | CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 12/04/2007 | US7304138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 12/04/2007 | US7304042 Potent inhibition of influenza virus by specifically designed short interfering RNA |
| 12/04/2007 | US7304040 Suppression of post-transplant arteriosclerosis |
| 12/04/2007 | US7303910 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 12/04/2007 | US7303895 Choline transport like (CTL) membrane proteins involved in choline transport |
| 12/04/2007 | US7303890 Proteins, genes encoding them and method of using the same |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | US7303868 Mutant bank |
| 12/04/2007 | CA2263705C Novel sandwich liposome complexes comprising a biologically active agent |
| 12/04/2007 | CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| 11/29/2007 | WO2007137303A2 Permeability of blood-brain barrier |
| 11/29/2007 | WO2007137301A2 Modulation of chrebp expression |
| 11/29/2007 | WO2007137239A2 Treatment of protein misfolding |
| 11/29/2007 | WO2007137237A2 Treatment of protein misfolding |
| 11/29/2007 | WO2007137156A2 Rnai modulation of aha and therapeutic uses thereof |
| 11/29/2007 | WO2007137149A2 Use of cathepsin k antagonists in bone production |
| 11/29/2007 | WO2007137117A2 Aptamer-directed drug delivery |
| 11/29/2007 | WO2007136989A2 Compounds and methods for modulating expression of dgat2 |
| 11/29/2007 | WO2007136988A2 Compounds and methods for modulating expression of gccr |
| 11/29/2007 | WO2007136910A2 Eimmunotherapy for immune suppressed patients |
| 11/29/2007 | WO2007136857A2 Hox compositions and methods |
| 11/29/2007 | WO2007136758A2 Sirna inhibition of p13k p85, p110, and akt2 and methods of use |
| 11/29/2007 | WO2007136707A2 Methods and compositions related to eosinophil regulation |
| 11/29/2007 | WO2007136107A1 Method of constructing gene transport support |
| 11/29/2007 | WO2007135426A2 Treatment of neurodegeneratives diseases |
| 11/29/2007 | WO2007135284A1 Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament |
| 11/29/2007 | WO2007135164A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |